SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CRIS, Curis (formerly CBMI) -- Ignore unavailable to you. Want to Upgrade?


To: wolfdog2 who wrote (139)3/30/1998 10:51:00 PM
From: Norton  Read Replies (1) | Respond to of 668
 
Good base today even during a down market...



To: wolfdog2 who wrote (139)3/31/1998 7:56:00 PM
From: Chuca Marsh  Respond to of 668
 
Is that the same thing I received in the mail today from IR at CBMI, I can't find it now, but I am a few towns away from them so maybe I got it early in the near mails ( US Postal Service -Letter Size) I will look and post later. It was in News Release format- the 23 March OP-1 Trail Data presented @ Am. Acad. of Orthopaedic Surgeons and postmarked 30 March 98.- However about 10% higher for the Autograft group. ...Befor ity said...The Radiographs improved for both groups at comparable rates throughout the 24 months follow up period, however, radiographic assessment of the number of patients with cortical bridgeing remained approximately 10 of the autograph group.
Dr Muschler noted that there is no evidence in the data to suggest that the radiographic differences observed resulted in a difference in clincal return to function or increase in re-operations. " So this mitagates that news alot. JMO. Hang tuff.
Chuca